Scientists at St. Jude Children’s Research Hospital and Dana-Farber Cancer Institute, USA, report the identification of a novel combination therapy...
Vous n'êtes pas connecté
To help accelerate research into new treatments for acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS), Thermo Fisher Scientific Inc., the world leader in serving science, is partnering with the National Cancer Institute (NCI) – part of the National Institutes of Health – on the
Scientists at St. Jude Children’s Research Hospital and Dana-Farber Cancer Institute, USA, report the identification of a novel combination therapy...
Scientists at St. Jude Children’s Research Hospital and Dana-Farber Cancer Institute, USA, report the identification of a novel combination therapy...
Acute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment...
Servier India, a subsidiary of the leading French pharmaceutical Servier Group, recently announced the launch of Ivosidenib (Tibsovo), an oral...
Servier India, a subsidiary of the leading French pharmaceutical Servier Group, recently announced the launch of Ivosidenib (Tibsovo), an oral...
Acute myeloid leukaemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment...
Acute myeloid leukaemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment...
Acute Myeloid Leukemia (AML) grows at lightning speed and demands urgent, personalised treatment, here’s why early diagnosis is critical.
Acute Myeloid Leukemia (AML) grows at lightning speed and demands urgent, personalised treatment, here’s why early diagnosis is critical.
AML is a silent but deadly blood cancer that’s claiming Indian lives due to delayed diagnosis and lack of access, here’s what an expert wants you...